CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $35,312,000 | +62.8% | 1,425,000 | +64.7% | 2.67% | +60.4% |
| Q1 2022 | $21,686,000 | +48.9% | 865,000 | +116.2% | 1.66% | +92.3% |
| Q4 2021 | $14,564,000 | -66.6% | 400,000 | -52.9% | 0.87% | -10.7% |
| Q1 2021 | $43,554,000 | -41.4% | 850,000 | -29.2% | 0.97% | -45.1% |
| Q4 2020 | $74,304,000 | -17.8% | 1,200,000 | -27.3% | 1.77% | -49.2% |
| Q3 2020 | $90,420,000 | -41.8% | 1,650,000 | -38.9% | 3.48% | -41.3% |
| Q2 2020 | $155,358,000 | +45.9% | 2,700,000 | +1.9% | 5.93% | +19.8% |
| Q1 2020 | $106,478,000 | -14.5% | 2,650,000 | -15.9% | 4.95% | -0.5% |
| Q4 2019 | $124,583,000 | +909.6% | 3,150,000 | +73.1% | 4.97% | +562.1% |
| Q3 2019 | $12,340,000 | -43.9% | 1,820,000 | -23.1% | 0.75% | -40.5% |
| Q2 2019 | $21,997,000 | -37.3% | 2,365,280 | -6.4% | 1.26% | -46.7% |
| Q1 2019 | $35,085,000 | – | 2,525,900 | – | 2.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |